Jennifer Chow
Chief Executive Officer presso CHIMERIC THERAPEUTICS LIMITED
Patrimonio netto: 184 955 $ in data 31/03/2024
Profilo
Jennifer Chow is currently the CEO, Managing & Executive Director at Chimeric Therapeutics Ltd.
(Australia).
She previously worked as the VP, Head-Global Marketing & Analytics at Kite Pharma, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 21/09/2023 | 9 450 924 ( 1.12% ) | 184 955 $ | 31/03/2024 |
Posizioni attive di Jennifer Chow
| Società | Posizione | Inizio |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Chief Executive Officer | 30/08/2021 |
Precedenti posizioni note di Jennifer Chow
| Società | Posizione | Fine |
|---|---|---|
| KITE PHARMA INC | Sales & Marketing | 01/01/2017 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Chow
